Detalhe da pesquisa
1.
The path to tuberculosis elimination: a renewed vision.
Eur Respir J
; 61(6)2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37080572
2.
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020.
Emerg Infect Dis
; 26(11): 2709-2712, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32917293
3.
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).
Eur Respir J
; 56(4)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32586885
4.
Effectiveness of pulmonary rehabilitation in severe asthma: a retrospective data analysis.
J Asthma
; 57(12): 1365-1371, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31317799
5.
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Lancet
; 392(10150): 821-834, 2018 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30215381
6.
Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe.
Eur Respir J
; 53(6)2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31023852
7.
ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update.
Eur Respir J
; 51(5)2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29678945
8.
Multi and extensively drug-resistant pulmonary tuberculosis: advances in diagnosis and management.
Curr Opin Pulm Med
; 24(3): 244-252, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29470252
9.
Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.
Emerg Infect Dis
; 23(10)2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28758888
10.
Effectiveness and safety of clofazimine in multidrug-resistant tuberculosis: a nationwide report from Brazil.
Eur Respir J
; 49(3)2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28331044
11.
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.
Eur Respir J
; 49(5)2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28529205
12.
Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review.
Int J Mol Sci
; 18(2)2017 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28178199
13.
Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices.
Eur Respir J
; 48(3): 808-17, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27492827
14.
Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study.
Eur Respir J
; 58(5)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34446465
15.
Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.
Eur Respir J
; 47(4): 1235-43, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26965290
16.
Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.
Eur Respir J
; 47(6): 1758-66, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27076583
17.
Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method.
Eur Respir J
; 48(4): 1160-1170, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27587552
18.
Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review.
Int J Mol Sci
; 17(3): 373, 2016 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26985890
19.
Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.
Clin Infect Dis
; 61Suppl 3: S102-18, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26409271
20.
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.
Eur Respir J
; 56(1)2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32457198